Science Explorer Back to mapMap
Discussion
Researcher · IBM (United States) · United States

Dave Levitan

Dave Levitan publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.

OpenAlex
World rank
#7,710,246
of 7,710,434 ranked researchers
Rank in United States
#1,627,001
of 1,627,098
Works
1,101
Citations
245
Citations per work
0.2
h-index
5
i10-index 4Top 89% in Oncology
Dave Levitan

What does Dave Levitan research?

Dave Levitan's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (12%).

Health Sciences: 546 works · 49.6% of their workMedicine: 546 works · 49.6% of their workOncology: 225 works · 20.4% of their workPulmonary and Respiratory Medicine: 216 works · 19.6% of their workSurgery: 56 works · 5.1% of their workHematology: 50 works · 4.5% of their workEverything else: 423 works · 38.4% of their workLife Sciences: 132 works · 12.0% of their workBiochemistry, Genetics and Molecular Biology: 132 works · 12.0% of their workMolecular Biology: 72 works · 6.5% of their workCancer Research: 61 works · 5.5% of their workTHEIR WORKDave Levitan1,101works
Life Sciences12%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine54649.6%
  2. Everything else42338.4%
    1. Biochemistry, Genetics and Molecular Biology13212.0%
  1. 1Oncology20% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Molecular Biology6% of their works
  4. 4Cancer Research6% of their works
  5. 5Surgery5% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Dave Levitan's research?

The keywords of their largest research topics: Chemotherapy, EGFR Mutations, Targeted Therapy, Radiotherapy, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Chemotherapy1622 topics
  2. EGFR Mutations1461 topic
  3. Targeted Therapy1461 topic
  4. Radiotherapy1432 topics
  5. BCR-ABL971 topic
  6. Imatinib971 topic
  7. Chronic Lymphocytic Leukemia951 topic
  8. Genomic Aberrations951 topic
  9. Breast Cancer911 topic
  10. HER2911 topic
  11. Immune Checkpoint Blockade821 topic
  12. PD-1 and PD-L1821 topic
  13. Breast Tumours721 topic
  14. Gene Expression721 topic
  15. CT Screening711 topic
  16. Lung Cancer711 topic
  17. Chemotherapy-Induced Peripheral Neuropathy691 topic
  18. Taxanes691 topic

Where does Dave Levitan work?

Dave Levitan's main affiliation in the publication record is IBM (United States), United States.

How many publications and citations does Dave Levitan have?

OpenAlex counts 1,101 works and 245 citations for Dave Levitan, an h-index of 5, ranking #7,710,246 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dave Levitan. Posts are plain text and can be reported.